Health / Health News |
New compound helps find early signs of liver damage
A new compound that binds to, and enables MRI imaging of, liver cells in the early stage of disease, has been developed by scientists.
Researchers report that, in imaging studies of animal models of liver disease, the new compound (a protein-based MRI contrast agent) can accurately detect early stages of chronic liver disease, including mild fibrosis.
The new compound was also able to assess the severity or stage of liver damage without the need of biopsy.
An invasive procedure that involves the surgical removal of liver tissue, biopsy is the current standard for diagnosing and staging chronic liver diseases. (National Institutes of Health)
OCTOBER 29, 2019
YOU MAY ALSO LIKE
Researchers in the United Kingdom established that poor hygiene by humans, specifically insufficient hand washing after defecation, is especially responsible for the spread of antibiotic-resistant — superbug — strains of Escerichia coli (E. coli) bacteria.
The researchers argue that if government policy made menu labelling mandatory, it could encourage restaurants to produce healthier options, leading to public health benefits.
A new study suggests that regular weekly aerobic exercise may slow or prevent cognitive decline in older adults who are at a high risk of developing Alzheimer's.
A new study shows that drugs like aspirin may lessen the adverse effects of air pollution exposure on lung function.